Suppliers and packagers for SEASONALE

SEASONALE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Teva Branded Pharm	SEASONALE	ethinyl estradiol; levonorgestrel	TABLET;ORAL	021544	NDA AUTHORIZED GENERIC	Teva Pharmaceuticals USA, Inc.	0555-9123-66	3 POUCH in 1 CARTON (0555-9123-66) / 1 BLISTER PACK in 1 POUCH / 1 KIT in 1 BLISTER PACK	2003-10-13

Suppliers for the Pharmaceutical Drug: Seasonale

Last updated: July 31, 2025

Introduction

Seasonale is an oral contraceptive widely used for birth control and menstrual cycle regulation. As a prescription medication, it comprises a combination of hormones designed to prevent pregnancy by inhibiting ovulation, altering cervical mucus, and modifying the uterine lining. Manufactured by Bayer Pharmaceuticals, Seasonale is marketed globally, with supply chains spanning multiple countries. This article explores the key suppliers involved in its production, from active pharmaceutical ingredient (API) sourcing to finished product distribution, and examines the broader implications for pharmaceutical supply chains.

---

Manufacturing and Supply Chain Overview

The production of Seasonale involves layered supply processes: sourcing of raw materials, manufacturing of APIs, formulation, packaging, and distribution. While Bayer remains the primary marketer, the complexity of global pharmaceutical manufacturing entails collaboration with numerous suppliers, often across multiple continents, to ensure quality, compliance, and continuity.

---

Active Pharmaceutical Ingredient (API) Suppliers

The core of Seasonale's manufacturing process involves the synthesis and procurement of two hormones: ethinyl estradiol (EE) and levonorgestrel. Both are synthetic hormones, and their quality and supply reliability are pivotal.

Ethinyl Estradiol Suppliers

Ethinyl estradiol is a synthetic estrogen extensively used in oral contraceptives. Major suppliers include:

• Shuangwei Pharmaceutical Co., Ltd. (China): A leading manufacturer of synthetic estrogens, supplying both domestic and international markets. Its process adheres to GMP standards approved by Chinese regulatory authorities.

• Cadila Pharmaceuticals (India): A prominent Indian generic pharmaceutical company providing high-quality ethnyl estradiol for global markets, including contraceptives like Seasonale.

• Sino Biopharmaceutical Limited (Hong Kong): Engages in manufacturing and distribution of APIs, including ethinyl estradiol, with manufacturing facilities compliant with international standards.

Levonorgestrel Suppliers

Levonorgestrel, a progestin, is sourced from:

• Bayer AG (Germany): As the original developer, Bayer remains a major supplier of levonorgestrel worldwide, ensuring high-purity API production with strict quality controls.

• Jiangsu Chia Tai Pharmaceutical (China): Provides levonorgestrel APIs meeting international standards, contributing to global contraceptive supply chains.

• Gedeon Richter Plc. (Hungary): Supplies levonorgestrel for various formulations, with a focus on European and other international markets.

---

API Manufacturing Trends and Regulatory Considerations

The reliance on Asian API manufacturers (China and India) has increased over recent decades, driven by cost efficiencies and high production volumes. However, regulatory oversight remains critical. Both the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) rigorously inspect API manufacturing facilities, imposing compliance requirements that influence supply stability.

Furthermore, geopolitical factors, trade policies, and pandemic-related disruptions have heightened concerns about supply chain resilience. Companies like Bayer often diversify their API sourcing, working with multiple suppliers and maintaining strategic stockpiles to mitigate shortages.

---

Formulation and Finished Pharmaceutical Goods (FPG) Suppliers

Beyond API procurement, the formulation of Seasonale involves excipients, encapsulation, and packaging. While Bayer orchestrates the final formulation and packaging, it collaborates with numerous contract manufacturing organizations (CMOs). These CMOs are located primarily in North America, Europe, and Asia, offering capabilities in tablet compression, coating, and blister packaging.

Key CMO Partners

• Samsung BioLogics (South Korea): Known for high-volume tablet manufacturing and packaging.

• Catalent, Inc. (USA): Provides formulation development, manufacturing, and packaging of oral contraceptives.

• Recipharm (Sweden): Supplies finished dosage forms to global markets, adhering to strict quality control protocols.

These partnerships enable Bayer to expand manufacturing capacity rapidly and ensure geographic distribution flexibility.

---

Distribution Channels and Regional Suppliers

Post-production, Seasonale is distributed through a network of wholesalers, pharmacies, and healthcare providers. Regional distributors often work with national regulatory agencies to ensure compliance and timely delivery. Major pharmaceutical distributors such as McKesson Corporation (USA), Alliance Healthcare (Europe), and local wholesalers in emerging markets play critical roles.

Supply chain robustness, especially in regions with less infrastructure, remains a challenge. The ongoing support and engagement with regional suppliers are vital for uninterrupted access to contraceptive options like Seasonale.

---

Regulatory and Quality Assurance in the Supply Chain

Regulatory compliance is a cornerstone of pharmaceutical supply chains. Suppliers must meet Good Manufacturing Practices (GMP), adhere to strict quality standards set by agencies like the FDA, EMA, and the World Health Organization (WHO).

Quality assurance involves rigorous testing for contaminants, potency, stability, and bioavailability. Non-compliance by any supplier can cause significant disruptions, prompting companies to implement comprehensive auditing, supplier qualification, and supply risk assessments.

---

Implications for Market Stability

The dependency on international suppliers introduces vulnerabilities — political instability, natural disasters, and pandemics can hinder API supply. Notably, the US and European markets have observed API shortages in recent years, emphasizing the need for diversified sourcing strategies.

Bayer, like other pharmaceutical companies, invests in supply chain resilience through regional manufacturing expansion and establishing multiple supplier relationships. This approach aims to secure consistent availability of Seasonale and similar contraceptives.

---

Key Takeaways

• The production of Seasonale hinges on high-quality APIs, primarily sourced from China, India, and Bayer’s own manufacturing facilities in Europe.

• Asian API suppliers dominate due to cost advantages but face regulatory and geopolitical challenges impacting supply stability.

• Contract manufacturing organizations in North America and Europe contribute significantly to formulation, packaging, and final product assembly.

• Regional distribution partnerships are critical for market accessibility, especially in emerging economies.

• Ensuring regulatory compliance and rigorous quality control across the supply chain is vital to prevent shortages and maintain product integrity.

• Diversification of suppliers and regional manufacturing capacity are strategic priorities for manufacturers to mitigate geopolitical and supply chain risks.

---

FAQs

1. Who are the primary API suppliers for Seasonale?
   The active pharmaceutical ingredients—ethinyl estradiol and levonorgestrel—are supplied mainly by Bayer AG, Chinese manufacturers such as Shuangwei Pharmaceutical, and Indian firms like Cadila Pharmaceuticals.

2. How do geopolitical factors affect Seasonale’s supply chain?
   geopolitical tensions, trade restrictions, and recent global disruptions have challenged API availability from major manufacturing hubs, prompting manufacturers to diversify sourcing and increase regional production capacities.

3. What role do contract manufacturing organizations play in Seasonale’s production?
   CMOs handle formulations, tablet compression, coating, packaging, and distribution, enabling Bayer to expand manufacturing capacity and adapt to regional demands efficiently.

4. Are there concerns regarding the quality of API suppliers?
   Yes. Regulatory agencies strictly audit and monitor API manufacturers. Non-compliance can lead to supply disruptions; therefore, suppliers undergo rigorous qualification and ongoing quality assessments.

5. What strategies are pharmaceutical companies implementing to ensure continuous supply?
   Companies diversify API sources, increase regional production facilities, maintain strategic stockpiles, and closely monitor supply chain risks to mitigate shortages and ensure reliable distribution of Seasonale.

---

References

[1] U.S. Food and Drug Administration (FDA). “API Manufacturing Regulations.” FDA.gov, 2022.

[2] European Medicines Agency (EMA). “Manufacturing and Quality Control of APIs.” EMA.europa.eu, 2023.

[3] Bayer Pharmaceuticals’ official website. “About Us.” Bayer.com, 2023.

[4] MarketWatch. “Global API Market Trends.” MarketWatch.com, 2022.

[5] WHO. “Guidelines on Good Manufacturing Practices (GMP) for Active Pharmaceutical Ingredients.” WHO.int, 2021.